Journals / Cukurova Medical Journal / 2015 / Cilt: 40 Sayı: Ek 1

Non-Ketotic Hyperglycinemia

Non-Ketotik Hiperglisinemi

Pages
117–121
Publication Date
2015-10-09
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this article we report a patient who came to the clinic with decreased absorbtion, widely hypotonia, myoclonic seizures and hiccups and who has been diagnosed as non ketotic hyperglycinemia.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:On the newborn period some metabolic diseases may cause encephalopathy clinic which can threat the life.
📊
Key Findings & Data:This is related with tke accumulation of metabolic intermediates ond the brain and their toxic effects.Babies are usually asymptomatic at birth.
💡
Conclusion & Impact:In this article we report a patient who came to the clinic with decreased absorbtion, widely hypotonia, myoclonic seizures and hiccups and who has been diagnosed as non ketotic hyperglycinemia.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Anahtar Kelimeler Hiperglisinemi · Ketotik Olmayan · Yenidoğanlar

Abstract

On the newborn period some metabolic diseases may cause encephalopathy clinic which can threat the life. This is related with tke accumulation of metabolic intermediates ond the brain and their toxic effects.Babies are usually asymptomatic at birth. By the accumulation of toxic metabolytes patients have the encephalopathy symptoms such as hypotonia, hypertonia, convulsions and lethargy. In this article we report a patient who came to the clinic with decreased absorbtion, widely hypotonia, myoclonic seizures and hiccups and who has been diagnosed as non ketotic hyperglycinemia.

Özet

Yenidoğan döneminde bazı metabolik hastalıklar hayatı tehdit eden ensefalopati tablosu olarak ortaya çıkar. Bu durum bazı metabolizma ara ürünlerinin beyinde birikerek toksik etkiler göstermesi ile ilişkilidir. Bebekler doğumda genelde asemptomatiktir. Yaşamın ilk günlerinde toksik metabolitlerin birikimi ile hastalarda yaygın hipotoni veya hipertoni, konvülzyonlar ve letarji gibi ensefalopati bulguları ortaya çıkar. Bu yazıda emmede azalma, yaygın hipotoni, miyoklonik nöbet ve hıçkırık nedeni ile gelen ve non-ketotik hiperglisinemi tanısı koyduğumuz bir infant sunulmuştur.

🔖

Cite This Article

ŞAN, M., ÇAĞAN, E., IŞIKAY, S., ŞAN, E., ÇAĞAN, H. (2015). Non-Ketotic Hyperglycinemia. Cukurova Medical Journal, Cilt: 40 Sayı: Ek 1, 117–121. https://ajindex.com/articles/56835

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Hamosh A, Maher JF, Bellus GA, Rasmussen SA, Johnston MV. Long-term use of high-dose benzoate and dextromethorphan for the treatment of nonketotic hyperglycinemia. J Pediatr. 1998;132:709-13. von WL, Simila S, Saukkonen AL, Koivisto M. Failure of strychnine treatment during the neonatal period in three Finnish children with nonketotic hyperglycinemia. Pediatrics. 1980;65:1166-9.
  2. Boneh A, Korman SH, Sato K, et al. A single nucleotide substitution that abolishes the initiator methionine codon of the GLDC gene is prevalent among patients with glycine encephalopathy in Jerusalem. J Hum Genet. 2005;50:230-4. Balfe BE. A survey of group practice in the United States, 1965. Public Health Rep. 1969;84:597-603. Rezvani I. Defects in metabolism of aminoacids. Nelson textbook of pediatrics. In: Kliegman RM BRJHSB, editor. Philadelphia: Saunders. 2007;549- 50. Schutgens RB, Ket JL, Hayasaka K, Tada K. Non- ketotic hyperglycinaemia due to a deficiency of T- protein in the glycine cleavage system in liver and brain. J Inherit Metab Dis. 1986;9:208-14. Cataltepe S, van Marter LJ, Kozakewich H, Wessel DL, Lee PJ, Levy HL. Pulmonary hypertension associated with nonketotic hyperglycinaemia. J Inherit Metab Dis. 2000;23:137-44.
  3. Van Hove JL, Kishnani PS, Demaerel P, et al. Acute hydrocephalus in nonketotic hyperglycemia. Neurology. 2000;54:754-6. Chung B. Non-ketotic Hyperglycinaemia: A Case Report and Review on Treatment. HK J Paediatr (New Series). 2002;152-6. Tastekin A. Rare case of neonatal hypotonia: Neonatal Nonketotic Hyperglycinemia. Turk J Med. Sci 2002;32:73-5.
  4. Tan ES, Wiley V, Carpenter K, Wilcken B. Non- ketotic hyperglycinemia is usually not detectable by tandem mass spectrometry newborn screening. Mol Genet Metab. 2007;90:446-8.
  5. Applegarth DA, Toone JR, Rolland MO, Black SH, Yim DK, Bemis G. Non-concordance of CVS and liver glycine cleavage enzyme in three families with non- ketotic hyperglycinaemia (NKH) leading to false negative prenatal diagnoses. Prenat Diagn. 2000;20:367-70.
  6. Kure S, Rolland MO, Leisti J, et al. Prenatal diagnosis of non-ketotic hyperglycinaemia: enzymatic diagnosis in 28 families and DNA diagnosis detecting prevalent Finnish and Israeli-Arab mutations. Prenat Diagn. 1999;19:717-20.
  7. Hamosh A, McDonald JW, Valle D, Francomano CA, Niedermeyer E, Johnston MV. Dextromethorphan and high-dose benzoate therapy for nonketotic hyperglycinemia in an infant. J Pediatr. 1992;121:131-5.
  8. Zammarchi E, Donati MA, Ciani F, Pasquini E, Pela I, Fiorini P. Fa